| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/17/1998 | CN1185180A Gene expression in mammalian cells |
| 06/17/1998 | CN1185178A Recombinant preduodenal lipases and polypeptide derivatives produced by plant, prodn. and use thereof |
| 06/17/1998 | CN1185160A Peptide and method for obtg. same |
| 06/17/1998 | CN1185115A 多粘菌素轭合物 Polymyxin conjugates |
| 06/17/1998 | CN1185114A Monomeric insulin analog formulations |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/17/1998 | CN1185106A Use of carbazole compounds for treating congestive heart failure |
| 06/17/1998 | CN1184673A FGF raw extraction polypeptide growth factor mixture, and extraction process therefor |
| 06/17/1998 | CN1038751C Cyclopeptides |
| 06/16/1998 | US5767373 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/16/1998 | US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 06/16/1998 | US5767274 Treating tumors or restenosis |
| 06/16/1998 | US5767263 Base-modified enzymatic nucleic acid |
| 06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
| 06/16/1998 | US5767260 A nucleic acid coding for two epitope-containing polypeptide joined by a peptide linker and attached to phospholipase a activating protein or tumor necrosis factor; antiinflammatory agents |
| 06/16/1998 | US5767258 Cell cycle regulatory gene |
| 06/16/1998 | US5767254 Method for making amino acid glycosides and glycopeptides |
| 06/16/1998 | US5767252 Neuronal cell growth factor, Narp |
| 06/16/1998 | US5767251 Polypeptides |
| 06/16/1998 | US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 06/16/1998 | US5767244 Protein-TRAF6 |
| 06/16/1998 | US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 06/16/1998 | US5767241 Soluble form of GMP-140 |
| 06/16/1998 | US5767240 Activity-dependent neurotrophic factor |
| 06/16/1998 | US5767239 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
| 06/16/1998 | US5767237 Antitumor agents |
| 06/16/1998 | US5767236 Linear therapeutic peptides |
| 06/16/1998 | US5767235 Sulfated tyosine |
| 06/16/1998 | US5767234 Interleukin agonists and antagonists; antiinflammatory and -arthritic agents; skin, liver and respiratory system disorders; immunology |
| 06/16/1998 | US5767160 Method and formulation of stimulating nitric oxide synthesis |
| 06/16/1998 | US5767156 Polyunsaturated fatty acids and uses thereof |
| 06/16/1998 | US5767125 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| 06/16/1998 | US5767122 Enantiomerically pure β-d-dioxolane nucleosides |
| 06/16/1998 | US5767118 4-Heterocyclic peperidines promote release of growth hormone |
| 06/16/1998 | US5767102 Antisense composition and method for treatment of CMV infection |
| 06/16/1998 | US5767097 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
| 06/16/1998 | US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 06/16/1998 | US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation |
| 06/16/1998 | US5767087 Administering purified glutamic acid-tryptophan dipeptide toincrease number of lymphocytes or karyocytes in non-human animal |
| 06/16/1998 | US5767086 Administering cytoprotective cell differentiation stimulant to bone marrow |
| 06/16/1998 | US5767085 Peptide derivatives |
| 06/16/1998 | US5767084 Method of treatment for cystic fibrosis and peptides for same |
| 06/16/1998 | US5767083 Inhibition of melanocyte stimulatting hormone |
| 06/16/1998 | US5767082 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
| 06/16/1998 | US5767080 Enhanced milk production in dairy cattle |
| 06/16/1998 | US5767079 Vision defects |
| 06/16/1998 | US5767078 Activation and dimerization of erythropoietin receptors to signal initiation; stimulation of erthrocytes and oxygen-carrying capcity of blood |
| 06/16/1998 | US5767077 Human Fc-γ receptor III |
| 06/16/1998 | US5767075 Inhibiting protein interactions |
| 06/16/1998 | US5767074 Comprises a soluble c-kit ligand protein and one or more hematopoietic factors selected from interleukins, granulocyte-macrophage-colony stimulating factor, granulocyte-colonyl stimulating factor or erythropoietin |
| 06/16/1998 | US5767071 Sevenmer cyclic peptide inhibitors of diseases involving αv β3 |
| 06/16/1998 | US5767069 Cyclosporins |
| 06/16/1998 | US5767068 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| 06/16/1998 | US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same |
| 06/16/1998 | US5767066 Medical application of bromelain |
| 06/16/1998 | US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4 |
| 06/16/1998 | US5767064 Soluble type II interleukin-1 receptors and methods |
| 06/16/1998 | US5767063 Human IL-8 receptor and antibodies thereto |
| 06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
| 06/16/1998 | US5766946 Monoclonal antibodies to glycoprotein P |
| 06/16/1998 | US5766942 Endoribonuclease activity |
| 06/16/1998 | US5766940 Plasmid and plasmid vector |
| 06/16/1998 | US5766939 Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
| 06/16/1998 | US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine |
| 06/16/1998 | US5766923 Isolated nucleic acid encoding ligands for FGFR |
| 06/16/1998 | US5766922 Functional ligands for the axonal cell rcognition molecule contactin |
| 06/16/1998 | US5766921 Hybrid protein C |
| 06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
| 06/16/1998 | US5766916 Fusion proteins; viricides |
| 06/16/1998 | US5766910 Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1, 6-N-acetylglucosaminyltransfrase gene family |
| 06/16/1998 | US5766897 Cysteine-pegylated proteins |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766884 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals |
| 06/16/1998 | US5766880 Lung cancer |
| 06/16/1998 | US5766878 Polynucleotides encoding a transcriptional response regulator of streptococcus pneumoniae |
| 06/16/1998 | US5766877 Genes encoding art, an agouti-related transcript |
| 06/16/1998 | US5766873 Administering n-acetylcysteine |
| 06/16/1998 | US5766866 Lymphocyte chemoattractant factor and uses thereof |
| 06/16/1998 | US5766863 Kinase receptor activation assay |
| 06/16/1998 | US5766856 Diagnostic method for evaluating advanced glycosylation endproducts using MAC-2 receptor |
| 06/16/1998 | US5766855 Peptide nucleic acids having enhanced binding affinity and sequence specificity |
| 06/16/1998 | US5766853 Method for identification of high affinity nucleic acid ligands to selectins |
| 06/16/1998 | US5766850 Human β2 integrin α subunit |
| 06/16/1998 | US5766848 Methods for identifying compounds which specifically bind a human betaine/GABA transporter |
| 06/16/1998 | US5766846 Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| 06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
| 06/16/1998 | US5766840 Purified antibody preparation |
| 06/16/1998 | US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section |
| 06/16/1998 | US5766633 Modified amino acid carrier, bioactive peptides |
| 06/16/1998 | US5766632 Method of using lectins for contraception |
| 06/16/1998 | US5766629 Nonionic surfactant, alkanol |
| 06/16/1998 | US5766624 Liposomal defensins |
| 06/16/1998 | US5766620 Buccal delivery of glucagon-like insulinotropic peptides |
| 06/16/1998 | US5766605 Locally administering to cholinergic neurons amount of toxin sufficient to cause denervation of the neurons |
| 06/16/1998 | US5766597 Vaccines providing immunity against plasmodium infections |
| 06/16/1998 | US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell |
| 06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
| 06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
| 06/16/1998 | US5766590 Therapeutic methods and pharmaceutical compositions |
| 06/16/1998 | US5766588 Tumor immunotherapy using anti-idiotypic antibodies |